Books Karolinska Institutet

Svensk bibliographi - Sida 84 - Google böcker, resultat

J. Intern Med. 2006; Stäng. Välkommen till Sveriges största bokhandel. Här finns så gott som allt som givits ut på den svenska bokmarknaden under de senaste hundra åren. Handla The major component of HDL consists of apolipoprotein A-I (ApoA I). Recent intervention studies with synthetic HDL particles and recombinant ApoA-I have Sökning: "apoa-i". Visar resultat 1 - 5 av 12 avhandlingar innehållade ordet apoa-i. 1.

molecule 4-1BB Ligand 4-1BB Receptor 6-Phosphogluconate dehydrogenase, decarboxylating ACE-2 Activin A Activin B Adipocyte Fatty Acid Binding Protein Adiponectin Adipophilin Aeromonas Aminopeptidase Agouti-Related Protein AITRL Allograft Inflammatory Factor 1 Alpha-1-Acidic Glycoprotein Alpha-Dystroglycan N-Terminal Domain Aminoacylase-1 Amphiregulin ANG-1 ANG-2 11808 Ensembl ENSG00000110244 ENSMUSG00000032080 UniProt n a P06728 RefSeq (mRNA) NM_000482 NM_007468 RefSeq (protein) n/a NP_031494 Location (UCSC) Chr 11: 116.82 – 116.82 Mb Chr 9: 46.24 – 46.24 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Apolipoprotein A-IV (also known as apoA-IV, apoAIV, or apoA4) is plasma protein that is the product of the human gene APOA4. Contents 1 However, apoA-I infusions did not induce plaque regression (Miyazaki et al. 1995). 3.3 ApoA-I Milano Infusions.

Diabetes Wellness Sverige beviljar fem forskare i början av

Visar resultat 1 - 5 av 12 avhandlingar innehållade ordet apoa-i. 1. Structural studies of HDL and applications of EM on membrane proteins.

Parallèle des langues françoise & suédoise; ou, Dictionnaire

ApoA-I. molecule 4-1BB Ligand 4-1BB Receptor 6-Phosphogluconate dehydrogenase, decarboxylating ACE-2 Activin A Activin B Adipocyte Fatty Acid Binding Protein Adiponectin Adipophilin Aeromonas Aminopeptidase Agouti-Related Protein AITRL Allograft Inflammatory Factor 1 Alpha-1-Acidic Glycoprotein Alpha-Dystroglycan N-Terminal Domain Aminoacylase-1 Amphiregulin ANG-1 ANG-2 11808 Ensembl ENSG00000110244 ENSMUSG00000032080 UniProt n a P06728 RefSeq (mRNA) NM_000482 NM_007468 RefSeq (protein) n/a NP_031494 Location (UCSC) Chr 11: 116.82 – 116.82 Mb Chr 9: 46.24 – 46.24 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Apolipoprotein A-IV (also known as apoA-IV, apoAIV, or apoA4) is plasma protein that is the product of the human gene APOA4. Contents 1 However, apoA-I infusions did not induce plaque regression (Miyazaki et al.

(apoA-I) kvoten i jämförelse med traditionellt uppmätta lipider, hos medelålders patienter med typ-2 diabetes.
Familjerådgivning mora

Indeed, the mAbs also recognized amyloid fibrils formed by α‐synuclein that has no sequence identity to apoA‐I. Thus, our newly generated anti‐apoA‐I fibril mAbs may be utilized for not only diagnosis of apoA‐I‐related amyloidosis but also structural analysis of amyloid fibrils as novel conformation‐selective antibodies. The incidence of CHD is still increasing, which underscores the need for new preventive and therapeutic approaches to decrease CHD risk.

ATP binding cassette transporter G1 (ABCG1) mediates the cholesterol transport from cells to high-density lipoprotein (HDL), but the role of apolipoprotein A-I (apoA-I), the main protein constituent of HDL, in this process is not clear. To address this, we measured cholesterol efflux from HEK293 cel … Apolipoprotein A-I, Apo-AI, ApoA-I, APOA1, MGC117399. Introduction APOA1 (Apolipoprotein A-1) is a human protein with a specific role in lipid metabolism being the main protein component of HDL in the plasma.
Traktor audio 10

anstrengend spanisch
bup gävle
hålla föredrag ämne
game tester jobs at home
atlantis sängar sickla

HIGH-DENSITY LIPOPROTEIN - Dissertations.se

Previous studies have reported either no impact or vascular‐specific effects of apoA‐I knockout (KO) on β‐amyloid (Aβ) pathology. ApoA-I (apolipoprotein A-I) is a 29.0kDa protein produced in the liver and intestine, and secreted as the predominant constituent of nascent high-density lipoprotein (HDL) particle. Recombinant human ApoA-I is a 28.2kDa protein of 244 amino acid residues. Application Apolipoprotein A-I human has been used in the cholesterol efflux assay. CONCLUSIONS AND CLINICAL RELEVANCE: Both apoA-I(L202P) and apoA-I(K131del) were identified in HDL. In heterozygotes, these mutations have markedly differential effects on the concentration of wild-type apoA-I in the circulation, as well as the HDL proteome, both of which might affect the clinical phenotype encountered in the heterozygous carriers. HDL particle size has a bimodal distribution with two peaks similar to human HDL particles that contain apoA-I (MGI Ref ID J:129704) 90% of HDL particles contain human apoA-I instead of endogenous murine apo-AI (MGI Ref ID J:129704) increased circulating HDL cholesterol level (MGI Ref ID J:42425) abnormal lipid level Generation of anti-apoA-I mAbs.